Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Morishima

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Journal of Medicinal Chemistry|December 14, 2001
A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residuesT Honma, T Yoshizumi, N Hashimoto, et al.
European Journal of Clinical Nutrition|September 14, 2007
The effect of Lactobacillus helveticus fermented milk on sleep and health perception in elderly subjectsS Yamamura, H Morishima, T Kumano-go, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 2: J-111,225, J-114,870, J-114,871 and related compoundsH Imamura, N Ohtake, A Shimizu, et al.
Peptides|April 5, 2001
Different binding sites for the neuropeptide Y Y1 antagonists 1229U91 and J-104870 on human Y1 receptorsT Kannoa, A Kanatani, S L Keen, et al.
Journal of Medicinal Chemistry|December 14, 2001
Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library designT Honma, K Hayashi, T Aoyama, et al.
Bioorganic & Medicinal Chemistry|June 16, 2001
Dicationic dithiocarbamate carbapenems with anti-MRSA activityH Imamura, N Ohtake, H Jona, et al.
Bioorganic & Medicinal Chemistry|September 26, 2000
Discovery of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenemsH Imamura, N Ohtake, A Shimizu, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Journal of Medicinal Chemistry|December 14, 2001
A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residuesT Honma, T Yoshizumi, N Hashimoto, et al.
European Journal of Clinical Nutrition|September 14, 2007
The effect of Lactobacillus helveticus fermented milk on sleep and health perception in elderly subjectsS Yamamura, H Morishima, T Kumano-go, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 2: J-111,225, J-114,870, J-114,871 and related compoundsH Imamura, N Ohtake, A Shimizu, et al.
Peptides|April 5, 2001
Different binding sites for the neuropeptide Y Y1 antagonists 1229U91 and J-104870 on human Y1 receptorsT Kannoa, A Kanatani, S L Keen, et al.
Journal of Medicinal Chemistry|December 14, 2001
Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library designT Honma, K Hayashi, T Aoyama, et al.
Bioorganic & Medicinal Chemistry|June 16, 2001
Dicationic dithiocarbamate carbapenems with anti-MRSA activityH Imamura, N Ohtake, H Jona, et al.
Bioorganic & Medicinal Chemistry|September 26, 2000
Discovery of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenemsH Imamura, N Ohtake, A Shimizu, et al.
Pageof 10